iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report)’s share price shot up 0.5% on Wednesday . The stock traded as high as $23.81 and last traded at $23.81. 336 shares changed hands during trading, a decline of 44% from the average session volume of 601 shares. The stock had previously closed at $23.68.
iShares Neuroscience and Healthcare ETF Stock Performance
The firm has a 50 day simple moving average of $25.19 and a two-hundred day simple moving average of $25.76. The stock has a market cap of $3.57 million, a P/E ratio of 28.31 and a beta of 0.72.
Institutional Trading of iShares Neuroscience and Healthcare ETF
An institutional investor recently bought a new position in iShares Neuroscience and Healthcare ETF stock. Jane Street Group LLC acquired a new position in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned approximately 6.77% of iShares Neuroscience and Healthcare ETF as of its most recent filing with the SEC.
iShares Neuroscience and Healthcare ETF Company Profile
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.
Read More
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- How to Invest in Insurance Companies: A Guide
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- ETF Screener: Uses and Step-by-Step Guide
- Alphabet’s Officially In A Bear Market—Time To Buy?
- When to Sell a Stock for Profit or Loss
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.